Stay informed with the latest updates for the inheritable blood disorders community.

Medical
Request for Proposals: WFH World Bleeding Disorders Registry
Request for Proposals: WFH World Bleeding Disorders Registry
Industry
FDA Accepts New Drug Application for AbbiVie’s HCV Combination Therapy
Industry
Bioverativ an Independent Company Spun off from Biogen
Bioverativ an Independent Company Spun off from Biogen
NBDF & Community
Compassion Has No Borders
Compassion Has No Borders
Industry
FDA Gives Breakthrough Designation to Hemophilia Gene Therapy
FDA Gives Breakthrough Designation to Hemophilia Gene Therapy
Medical
Call for Research Poster Abstracts
Call for Research Poster Abstracts
Medical
Inhibitor Chapter Updated in Nurses’ Guide to Bleeding Disorders
Wellness in People with Bleeding Disorders Updated in Nurses’ Guide
Advocacy & Legislative
NHF Supports Senate Bill to Stop Spread of Short-Term Plans
How to Advocate to Protect Access to Health Insurance
Advocacy & Legislative
Updated Patient Assistance Resource—Programs to Help Cover Your Insurance Costs
Updated Patient Assistance Resource—Programs to Help Cover Your…
NBDF & Community
Design the 2017 Hemophilia Walk T-shirt!
Design the 2017 Hemophilia Walk T-shirt!
Advocacy & Legislative
Update on Congressional Actions Regarding the Affordable Care Act
Update on Congressional Actions Regarding the Affordable Care Act
Industry
GenVec and WU Enter Hemophilia Therapies Agreement
GenVec and WU Enter Hemophilia Therapies Agreement
Industry
FDA will Review LFB's Application for Recombinant Factor VIIa Therapy
FDA will Review LFB's Application for Recombinant Factor VIIa Therapy
Industry
Sangamo Receives FDA Approval for Hemophilia A Gene Therapy Trial
Sangamo Receives FDA Approval for Hemophilia A Gene Therapy Trial
Industry
Sangamo and Pfizer Announce First Patient Treated in Hemophilia A Gene Therapy Trial
BioMarin’s Hemophilia A Gene Therapy Trial Demonstrates Increased FVIII…